
Pharma-focused, on-premise-leaning (now cloud-compatible) stability study manager that pre-registers ICH-aligned protocols, auto-schedules pull points, tracks chamber-bound samples, captures instrument data, runs OOT/trend analysis and produces dossier-ready stability reports for QA, QC and regulatory affairs teams.
CaliberLIMS Stability Module ships as one of 16+ modules inside CaliberLIMS 4.0 — the vendor's flagship LIMS platform. Oriented to ICH Q1A(R2), Q1B (photostability), Q1D (bracketing/matrixing) and Q1E (data evaluation) workflows used by formulations, API and biopharma QC labs.
Caliber sells a single pharma-tuned LIMS rather than separate industry editions; the stability module is enabled within that pharma build. Sits inside the CaliberLIMS 4.0 release announced at Caliber Commune 2024. Vendor copy emphasizes pre-defined stability protocols, automatic Analytical Reference (AR) number generation, station-by-station test execution, COA generation, graphical trend visualization and built-in audit trails to satisfy 21 CFR Part 11.
A 2024 Caliber resource article explicitly anchors the stability module to ICH conditions of 25°C/60% RH (long-term, 12 months), 40°C/75% RH (accelerated, 6 months) and 30°C/65% RH (intermediate, 6 months), and references ICH Q1A(R2) compliance. Reference customers concentrate in Indian generics and emerging-markets formulations, with MSN Laboratories and Ajanta Pharma the largest named. The module is commonly deployed under a "paperless lab" positioning alongside the broader CaliberLIMS environment.
CaliberLIMS 4.0 is sold as a pharma-tuned LIMS rather than separate industry editions; the stability module is enabled within that pharma build. A separate adjacent product, Caliber Pet-LIMS, exists for oil/petrochemical labs.
Historically on-premise; CaliberLIMS 4.0 described as "cloud-compatible" and "cloud-ready" per Capterra. Vendor publishes no SaaS multi-tenant offering, no public AWS/Azure/GCP region list, no separately priced cloud product page. Most published customer references are on-premise. A 2023 Capterra reviewer flags Caliber's "cloud journey" as still maturing.
A 2023 G2 reviewer notes pre-4.0 versions require Internet Explorer; 4.0 marketing claims access "across various devices, browsers, and languages." API available per GetApp; REST/GraphQL/webhook details not published. Named connectors: SAP, Empower (Waters), OpenLab CDS, generic ERP/QMS/DMS/CMS/MES. SSO providers, mobile apps, data residency not publicly documented.
Subscription-based per Capterra India listing — starting price ₹150,000.00 per year. The U.S. Capterra page references "$150000.00 per User, Per Month" which reads as a data-entry artifact. No public pricing beyond the listed starting figure; Caliber requires a personalized quote. No public free trial; demo via caliberuniversal.com.
Third-party (ITQlick) reports CaliberLIMS pricing starts at approximately US$1,500–$2,000 per user per year, implementation $5K–$20K for SMB and exceeding $50K for enterprise. These are third-party estimates, not vendor-published. Minimum commitments, setup fees, validation-support fees not published.
Typical timeline not published with specificity. Reviewer commentary mentions implementation takes longer than expected ("Lots of time is taking for implementation," 2023 Capterra). MSN Laboratories implementation started in 2010 and extended across multiple sites over years. Mid-cap multi-module rollouts (stability + sample management + reporting) likely 6–12+ months end-to-end including PQ.
Implementation, training, and post-go-live support are bundled as professional services per project; no published rate card. Caliber Commune is the annual user community event. Migration to Excel/CSV is implied; no public migration path from other LIMS platforms is documented.
Reviewer commentary also cites slow instrument-parser development, OCR-on-PDF reading for non-Empower CDS limited to simple tables, performance under concurrent users, slow enhancement turnaround, and legacy IE dependency on pre-4.0 deployments.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Users report strong end-to-end traceability and audit readiness. Capterra reviewer: "We are using Caliber LIMS from 2020. Our lab is completely Paperless lab. We are always ready for any Audits. We are successfully completed USFDA, ANVISA, EUGMP and 450 Customer Audits successfully." Reviewers praise ease of use for routine QC operations, instrument integration via Empower, section-worksheet functionality pulling data from initial batch into multi-batch stability comparisons, and responsive Caliber support during regulatory audits and PQ execution.
Users report dated UI ("design and layouts are like older template"), limited end-user-configurable dashboards and analytics, slowness under multi-user load, delayed feature enhancements ("Currently not providing Enhancements based on requirements of different customers"), time-consuming instrument-parser development, Internet Explorer dependency on pre-4.0 deployments, and limited non-Empower CDS integration ("Data collection from non-Empower based instruments are limited to OCR reading of PDF files"). Several reviewers describe post-implementation support gaps and slow turnaround on customization requests. Reviewer pool heavily concentrated among India-based pharma users.
Share your experience with CaliberLIMS Stability Module anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section